Read this in The Manila Times digital edition.
The Food and Drugs Administration (FDA) on Monday echoed an earlier warning by the World Health Organization (WHO) against four "substandard" cough syrups for children.
The WHO tagged the cough syrups manufactured by India-based Maiden Pharmaceutical Ltd. under the brands Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup as unsafe for consumption because they contain "toxic ingredients."
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.